Showing results (91-100 of 215) with videos related to
Sort By:
Pageof 22
Neuro-Oncology|November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse gliomaTejus A Bale, Justin T Jordan, Otto Rapalino, et al.NMR in Biomedicine|October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B0 -shim array coils at 3 TBernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.Journal of Neuro-Oncology|September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective studyXiaojie Ding, Zheng Wang, Di Chen, et al.The Oncologist|February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic ControlChristopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.Operative Neurosurgery (Hagerstown, Md.)|September 23, 2025
Relationships Between Surgical Approach, Tumor Classification Scheme, and Early Neurocognitive Outcome After Awake Craniotomy for Resection of Insular GliomaEvan D Bander, Kyle R Noll, Romulo A Andrade de Almeida, et al.Nature Communications|April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarateOvidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.Journal of Neurosurgery|March 30, 2019
Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mappingBryan D Choi, Daniel K Lee, Jimmy C Yang, et al.Cancer Cell|October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaChristian J Braun, Monica Stanciu, Paul L Boutz, et al.Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.Neuro-Oncology|December 6, 2013
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.Pageof 22